Metabolomic changes in fatty liver can be modified by dietary protein and calcium during energy restriction
AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium. METHODS: Liver metabolo...
Saved in:
Cover
Loading…
Abstract | AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium. METHODS: Liver metabolomic profile of lean and obese C57BI/6J mice (n = 10/group) were compared with two groups of weight-reduced mice. ER was performed on control diet and whey protein-based high-calcium diet (whey + Ca). The metabolomic analyses were performed using the UPLC/MS based lipidomic platform and the HPLC/MS/MS based primary metabolite platform.
RESULTS: ER on both diets significantly reduced hepatic lipid accumulation and lipid droplet size, while only whey + Ca diet significantly decreased blood glucose (P 〈 0.001) and serum insulin (P 〈 0.01). In hepatic lipid species the biggest reduction was in the level of triacylglycerols and cerarnides while the level of cholesterol esters was significantly increased during ER. Interestingly, diacylglycerol to phospholipid ratio, an indicator of relative amount of diabetogenic diglyceride species, was increased in the control ER group, but decreased in the whey + Ca ER group (P 〈 0.001, vs obese). ER on whey + Ca diet also totally reversed the obesity induced increase in the relative level of lipotoxic cerarnides (P 〈 0.001, vs obese; P 〉 0.05, vs lean). These changes were accompanied with up-regulated TCA cycle and pentose phosphate pathway rnetabolites.
CONCLUSION: ER-induced changes on hepatic rnetabolornic profile can be significantly affected by dietary protein source. The therapeutic potential of whey protein and calcium should be further studied. |
---|---|
AbstractList | AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium.
METHODS: Liver metabolomic profile of lean and obese C57Bl/6J mice (n = 10/group) were compared with two groups of weight-reduced mice. ER was performed on control diet and whey protein-based high-calcium diet (whey + Ca). The metabolomic analyses were performed using the UPLC/MS based lipidomic platform and the HPLC/MS/MS based primary metabolite platform.
RESULTS: ER on both diets significantly reduced hepatic lipid accumulation and lipid droplet size, while only whey + Ca diet significantly decreased blood glucose (P < 0.001) and serum insulin (P < 0.01). In hepatic lipid species the biggest reduction was in the level of triacylglycerols and ceramides while the level of cholesterol esters was significantly increased during ER. Interestingly, diacylglycerol to phospholipid ratio, an indicator of relative amount of diabetogenic diglyceride species, was increased in the control ER group, but decreased in the whey + Ca ER group (P < 0.001, vs obese). ER on whey + Ca diet also totally reversed the obesity induced increase in the relative level of lipotoxic ceramides (P < 0.001, vs obese; P > 0.05, vs lean). These changes were accompanied with up-regulated TCA cycle and pentose phosphate pathway metabolites.
CONCLUSION: ER-induced changes on hepatic metabolomic profile can be significantly affected by dietary protein source. The therapeutic potential of whey protein and calcium should be further studied. R5; AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium.METHODS: Liver metabolomic profile of lean and obese C57BI/6] mice (n = 10/group) were compared with two groups of weight-reduced mice. ER was performed on control diet and whey protein-based high-calcium diet (whey + Ca). The metabolomic an alyses were performed using the UPLC/MS based lipidomic platform and the HPLC/MS/MS based primary metabolite platform.RESULTS: ER on both diets significantly reduced hepatic lipid accumulation and lipid droplet size, while only whey + Ca diet significantly decreased blood glucose (P < 0.001) and serum insulin (P < 0.01).In hepatic lipid species the biggest reduction was in the level of triacylglycerols and ceramides while the level of cholesterol esters was significantly increased during ER. Interestingly, diacylglycerol to phospholipidratio, an indicator of relative amount of diabetogenic diglyceride species, was increased in the control Ergroup, but decreased in the whey + Ca ER group (P< 0.001, vs obese). ER on whey + Ca diet also totally reversed the obesity induced increase in the relative level of lipotoxic ceramides (P < 0.001, vs obese; P> 0.05, vs lean). These changes were accompanied with up-regulated TCA cycle and pentose phosphate pathway metabolites.CONCLUSION: ER-induced changes on hepatic metabolomic profile can be significantly affected by dietary protein source. The therapeutic potential of whey protein and calcium should be further studied. AIMTo characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium. METHODSLiver metabolomic profile of lean and obese C57Bl/6J mice (n = 10/group) were compared with two groups of weight-reduced mice. ER was performed on control diet and whey protein-based high-calcium diet (whey + Ca). The metabolomic analyses were performed using the UPLC/MS based lipidomic platform and the HPLC/MS/MS based primary metabolite platform. RESULTSER on both diets significantly reduced hepatic lipid accumulation and lipid droplet size, while only whey + Ca diet significantly decreased blood glucose (P < 0.001) and serum insulin (P < 0.01). In hepatic lipid species the biggest reduction was in the level of triacylglycerols and ceramides while the level of cholesterol esters was significantly increased during ER. Interestingly, diacylglycerol to phospholipid ratio, an indicator of relative amount of diabetogenic diglyceride species, was increased in the control ER group, but decreased in the whey + Ca ER group (P < 0.001, vs obese). ER on whey + Ca diet also totally reversed the obesity induced increase in the relative level of lipotoxic ceramides (P < 0.001, vs obese; P > 0.05, vs lean). These changes were accompanied with up-regulated TCA cycle and pentose phosphate pathway metabolites. CONCLUSIONER-induced changes on hepatic metabolomic profile can be significantly affected by dietary protein source. The therapeutic potential of whey protein and calcium should be further studied. AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium. METHODS: Liver metabolomic profile of lean and obese C57Bl/6J mice ( n = 10/group) were compared with two groups of weight-reduced mice. ER was performed on control diet and whey protein-based high-calcium diet (whey + Ca). The metabolomic analyses were performed using the UPLC/MS based lipidomic platform and the HPLC/MS/MS based primary metabolite platform. RESULTS: ER on both diets significantly reduced hepatic lipid accumulation and lipid droplet size, while only whey + Ca diet significantly decreased blood glucose ( P < 0.001) and serum insulin ( P < 0.01). In hepatic lipid species the biggest reduction was in the level of triacylglycerols and ceramides while the level of cholesterol esters was significantly increased during ER. Interestingly, diacylglycerol to phospholipid ratio, an indicator of relative amount of diabetogenic diglyceride species, was increased in the control ER group, but decreased in the whey + Ca ER group ( P < 0.001, vs obese). ER on whey + Ca diet also totally reversed the obesity induced increase in the relative level of lipotoxic ceramides ( P < 0.001, vs obese; P > 0.05, vs lean). These changes were accompanied with up-regulated TCA cycle and pentose phosphate pathway metabolites. CONCLUSION: ER-induced changes on hepatic metabolomic profile can be significantly affected by dietary protein source. The therapeutic potential of whey protein and calcium should be further studied. AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium. METHODS: Liver metabolomic profile of lean and obese C57BI/6J mice (n = 10/group) were compared with two groups of weight-reduced mice. ER was performed on control diet and whey protein-based high-calcium diet (whey + Ca). The metabolomic analyses were performed using the UPLC/MS based lipidomic platform and the HPLC/MS/MS based primary metabolite platform. RESULTS: ER on both diets significantly reduced hepatic lipid accumulation and lipid droplet size, while only whey + Ca diet significantly decreased blood glucose (P 〈 0.001) and serum insulin (P 〈 0.01). In hepatic lipid species the biggest reduction was in the level of triacylglycerols and cerarnides while the level of cholesterol esters was significantly increased during ER. Interestingly, diacylglycerol to phospholipid ratio, an indicator of relative amount of diabetogenic diglyceride species, was increased in the control ER group, but decreased in the whey + Ca ER group (P 〈 0.001, vs obese). ER on whey + Ca diet also totally reversed the obesity induced increase in the relative level of lipotoxic cerarnides (P 〈 0.001, vs obese; P 〉 0.05, vs lean). These changes were accompanied with up-regulated TCA cycle and pentose phosphate pathway rnetabolites. CONCLUSION: ER-induced changes on hepatic rnetabolornic profile can be significantly affected by dietary protein source. The therapeutic potential of whey protein and calcium should be further studied. To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether the effect of energy restriction can be further enhanced by modification of dietary protein source and calcium. Liver metabolomic profile of lean and obese C57Bl/6J mice (n = 10/group) were compared with two groups of weight-reduced mice. ER was performed on control diet and whey protein-based high-calcium diet (whey + Ca). The metabolomic analyses were performed using the UPLC/MS based lipidomic platform and the HPLC/MS/MS based primary metabolite platform. ER on both diets significantly reduced hepatic lipid accumulation and lipid droplet size, while only whey + Ca diet significantly decreased blood glucose (P < 0.001) and serum insulin (P < 0.01). In hepatic lipid species the biggest reduction was in the level of triacylglycerols and ceramides while the level of cholesterol esters was significantly increased during ER. Interestingly, diacylglycerol to phospholipid ratio, an indicator of relative amount of diabetogenic diglyceride species, was increased in the control ER group, but decreased in the whey + Ca ER group (P < 0.001, vs obese). ER on whey + Ca diet also totally reversed the obesity induced increase in the relative level of lipotoxic ceramides (P < 0.001, vs obese; P > 0.05, vs lean). These changes were accompanied with up-regulated TCA cycle and pentose phosphate pathway metabolites. ER-induced changes on hepatic metabolomic profile can be significantly affected by dietary protein source. The therapeutic potential of whey protein and calcium should be further studied. |
Author | Taru K Pilvi Tuulikki Seppanen-Laakso Helena Simolin Pier Finckenberg Anne Huotari Karl-Heinz Herzig Riitta Korpela Matej Oresic Eero M Mervaala |
AuthorAffiliation | Institute of Biomedicine, Pharmacology, Biomedicum Helsinki, PO Box 63, FI-00014 University of Helsinki, Helsinki FI-00390, Finland Foundation for Nutrition Research, PO Box 30, Helsinki FI-00390, Finland; Valio Ltd, Research Center, PO Box 30, Valio, Helsinki FI-00039, Finland VTT Technical Research Centre of Finland, Tietotie 2, VTT FI-02044, Finland A. I. Virtanen Institute for Molecular Sciences, PO Box 1627, University of Kuopio, Kuopio FI-70211, Finland Department of Internal Medicine, Kuopio University Hospital, PO Box 1777, Kuopio FI-70211, Finland; Institute of Biomedicine, Department of Physiology, and Biocenter of Oulu PO Box 5000, University of Oulu, Oulu FI-90014, Finland |
AuthorAffiliation_xml | – name: Institute of Biomedicine,Pharmacology,Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,elsinki FI-00390,Finland;Foundation for Nutrition Research,PO Box 30,Helsinki FI-00390,Finland%VTT Technical Research Centre of Finland,Tietotie 2,VTT FI-02044,Finland%Institute of Biomedicine,Pharmacology, Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,Helsinki FI-00390,Finland%A.I.Virtanen Institute for Molecular Sciences,PO Box 1627,University of Kuopio,Kuopio FI-70211,Finland%A.I.Virtanen Institute for Molecular Sciences,PO Box 1627,University of Kuopio,Kuopio FI-70211, Finland;Department of Internal Medicine,Kuopio University Hospital,PO Box 1777,Kuopio FI-70211,Finland;Institute of Biomedicine,Department of Physiology,and Biocenter of Oulu PO Box 5000,University of Oulu,Oulu FI-90014,Finland%Institute of Biomedicine, Pharmacology, Biomedicum Helsinki, PO Box 63, FI-00014 University of Helsinki,elsinki FI-00390,Finland;Foundation for Nutrition Research,PO Box 30,Helsinki FI-00390,Finland%Institute of Biomedicine,Pharmacology,Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,elsinki FI-00390, Finland |
Author_xml | – sequence: 1 givenname: Taru-K surname: Pilvi fullname: Pilvi, Taru-K organization: University of Helsinki, Helsinki FI-00390, Finland – sequence: 2 givenname: Tuulikki surname: Seppanen-Laakso fullname: Seppanen-Laakso, Tuulikki – sequence: 3 givenname: Helena surname: Simolin fullname: Simolin, Helena – sequence: 4 givenname: Piet surname: Finckenberg fullname: Finckenberg, Piet – sequence: 5 givenname: Anne surname: Huotari fullname: Huotari, Anne – sequence: 6 givenname: Karl-Heinz surname: Herzig fullname: Herzig, Karl-Heinz – sequence: 7 givenname: Riitta surname: Korpela fullname: Korpela, Riitta – sequence: 8 givenname: Matej surname: Oresic fullname: Oresic, Matej – sequence: 9 givenname: Eero-M surname: Mervaala fullname: Mervaala, Eero-M |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18680224$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-70920$$DView record from Swedish Publication Index |
BookMark | eNpVkctvEzEQxi1URNPCiTuyEOICCfZ4H_YFqSpPqYgLcLW8fmyc7tqpvdso_z0OiYAerDn4N998M98FOgsxWISeU7JibcXf7Tb9ilarqmrgEVoAULEEXpEztKCEtEvBoD1HFzlvCAHGaniCzilvOAGoFuj2m51UF4c4eo31WoXeZuwDdmqa9njw9zZhrQLuLB6j8c5bg7s9Nr60pT3epjjZgqtgCjZoP4_YzMmHHttgU7_HyeYpeT35GJ6ix04N2T471Uv089PHH9dfljffP3-9vrpZ6qqFaWlYZ1pqLK3B6Ap0p3jFWjC2pkQI0WhX10wDq2vnOg1akdYQ4rhSjQAOhF2it0fdvLPbuZPb5MdiVkbl5Qf_60rG1Jc3y5aIP_j7I17Y0Rptw5TU8KDr4U_wa9nHewkto9DSIvDqKLBTwZULyk2cUygbyhINEMKBE9IU7PVpTop3czmLHH3WdhhUsHHOshFM1A3hBXxzBHWKOSfr_nqhRB4iP-hKWslD5IV-8b_9f-wp4wK8PMmtY-jvSjayU_rW-cGWFQSvRYF-A7_atvQ |
CitedBy_id | crossref_primary_10_1016_j_idairyj_2021_105269 crossref_primary_10_1155_2011_525094 crossref_primary_10_3390_nu13072451 crossref_primary_10_1016_j_numecd_2009_04_018 crossref_primary_10_1371_journal_pone_0088904 crossref_primary_10_1017_jns_2019_12 crossref_primary_10_1016_j_idairyj_2011_03_006 crossref_primary_10_1186_1476_511X_10_57 crossref_primary_10_1089_omi_2010_0109 crossref_primary_10_1002_oby_20440 crossref_primary_10_1016_j_advnut_2024_100252 crossref_primary_10_1631_jzus_B1400255 crossref_primary_10_1080_10408398_2010_549596 crossref_primary_10_1021_acs_jproteome_6b00336 crossref_primary_10_1111_apha_12436 crossref_primary_10_5851_kosfa_2015_35_5_653 |
Cites_doi | 10.1053/j.gastro.2007.03.055 10.1016/j.bbalip.2007.07.007 10.1093/jn/134.11.3054 10.1016/j.plipres.2005.11.002 10.1161/ATVBAHA.107.147538 10.1016/S0163-7827(01)00020-0 10.2337/dc06-0256 10.1002/hep.21763 10.1186/1752-0509-1-12 10.1093/ajcn/22.9.1161 10.1016/S0531-5565(02)00202-4 10.2337/db07-0111 10.1136/jech.2006.053157 10.1136/jech.2006.052126 10.1093/bioinformatics/btk039 10.1038/oby.2003.52 10.1017/S0007114507764760 10.1096/fj.00-0584fje 10.1001/archinte.165.9.997 10.2337/diacare.24.10.1758 10.1152/ajpendo.1999.277.2.E352 10.1038/sj.ijo.0802880 10.1016/j.jnutbio.2007.01.009 10.2217/14622416.7.7.1077 10.1186/1471-2105-6-179 10.1194/jlr.R600022-JLR200 10.1016/S0014-5793(00)01950-5 10.1080/07315724.2005.10719502 10.1093/ajcn/82.3.523 10.1371/journal.pgen.0030064 10.1016/B978-012330215-1/50008-9 10.1001/jama.287.16.2081 10.1074/jbc.M406499200 10.1371/journal.pone.0000097 10.1080/07853890510037383 10.1038/oby.2005.144 10.1073/pnas.0707060104 10.2337/diacare.28.12.2926 10.1093/ajcn/86.2.285 10.1152/physiolgenomics.00084.2006 |
ClassificationCodes | R5 |
ContentType | Journal Article |
Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. 2008 The WJG Press and Baishideng. All rights reserved. 2008 |
Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. – notice: 2008 The WJG Press and Baishideng. All rights reserved. 2008 |
DBID | 2RA 92L CQIGP W91 ~WA CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 2B. 4A8 92I 93N PSX TCJ 5PM AABEP ADTPV AOWAS D8T D91 ZZAVC |
DOI | 10.3748/wjg.14.4462 |
DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) PubMed Central (Full Participant titles) SWEPUB Örebro universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Örebro universitet SwePub Articles full text |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Metabolomic changes in fatty liver can be modified by dietary protein and calcium during energy restriction |
EISSN | 2219-2840 |
EndPage | 4472 |
ExternalDocumentID | oai_DiVA_org_oru_70920 wjg200828006 10_3748_wjg_14_4462 18680224 27985924 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Foundation for Nutrition Research, Academy of Finland, Sigrid Juselius Foundation and Valio Ltd., Helsinki,Finland |
GroupedDBID | --- 123 29R 2B. 2C~ 2RA 2WC 36B 53G 5VR 8WL 92F 92I 92L 93N 93R AAKDD ACGFO AENEX AFUIB ALMA_UNASSIGNED_HOLDINGS CCEZO CDYEO CHBEP CIEJG CQIGP CS3 CW9 DIK DU5 E3Z EBS EJD EMB F5P FA0 FRP GX1 HYE M~E OK1 P2P RNS RPM SV3 TCJ TGQ TR2 W91 WFFXF XSB ~WA CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 4A8 PSX 5PM AABEP ADTPV AOWAS D8T D91 ZZAVC |
ID | FETCH-LOGICAL-c472t-d3bd71de152dc42cba84372de5109996cf553c2355ffbc2ca07d00f8aa6928203 |
IEDL.DBID | RPM |
ISSN | 1007-9327 2219-2840 |
IngestDate | Sat Aug 24 00:16:22 EDT 2024 Thu Aug 31 06:35:47 EDT 2023 Wed Nov 06 04:37:42 EST 2024 Fri Oct 25 09:17:25 EDT 2024 Fri Aug 23 03:59:57 EDT 2024 Wed Oct 16 00:47:27 EDT 2024 Fri Nov 25 02:42:07 EST 2022 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 28 |
Keywords | Energy restriction Metabolomics Dietary calcium Fatty liver Whey protein |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c472t-d3bd71de152dc42cba84372de5109996cf553c2355ffbc2ca07d00f8aa6928203 |
Notes | Energy restriction Metabolomics Fatty liver 14-1219/R Fatty liver; Metabolomics; Energy restriction; Whey protein; Dietary calcium Dietary calcium R575.5 Whey protein ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Fax: +358-9-19125364 Correspondence to: Eero M Mervaala, MD, Professor, Institute of Biomedicine, Pharmacology, Biomedicum Helsinki, PO Box 63, University of Helsinki, Helsinki FI-00390, Finland. eero.mervaala@helsinki.fi Author contributions: Pilvi TK designed and conducted the study, analysed the data and prepared the manuscript. Seppänen-Laakso T, Simolin H and Orešič M did the metabolomic analyses. Huotari A and Herzig KH conducted the metabolic performance and calorimetry tests. Korpela R and Mervaala EM were involved in designing the study, reviewing and interpreting the results and all authors were involved in drafting the manuscript. Telephone: +358-9-19125355 |
OpenAccessLink | https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-70920 |
PMID | 18680224 |
PQID | 69395608 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | swepub_primary_oai_DiVA_org_oru_70920 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2731271 wanfang_journals_wjg200828006 proquest_miscellaneous_69395608 crossref_primary_10_3748_wjg_14_4462 pubmed_primary_18680224 chongqing_backfile_27985924 |
PublicationCentury | 2000 |
PublicationDate | 2008-07-28 |
PublicationDateYYYYMMDD | 2008-07-28 |
PublicationDate_xml | – month: 07 year: 2008 text: 2008-07-28 day: 28 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | World journal of gastroenterology : WJG |
PublicationTitleAlternate | World Journal of Gastroenterology |
PublicationTitle_FL | WORLD JOURNAL OF GASTROENTEROLOGY |
PublicationYear | 2008 |
Publisher | Department of Internal Medicine,Kuopio University Hospital,PO Box 1777,Kuopio FI-70211,Finland Foundation for Nutrition Research,PO Box 30,Helsinki FI-00390,Finland%Institute of Biomedicine,Pharmacology,Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,elsinki FI-00390, Finland Institute of Biomedicine,Department of Physiology,and Biocenter of Oulu PO Box 5000,University of Oulu,Oulu FI-90014,Finland%Institute of Biomedicine, Pharmacology, Biomedicum Helsinki, PO Box 63, FI-00014 University of Helsinki,elsinki FI-00390,Finland Foundation for Nutrition Research,PO Box 30,Helsinki FI-00390,Finland%VTT Technical Research Centre of Finland,Tietotie 2,VTT FI-02044,Finland%Institute of Biomedicine,Pharmacology, Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,Helsinki FI-00390,Finland%A.I.Virtanen Institute for Molecular Sciences,PO Box 1627,University of Kuopio,Kuopio FI-70211,Finland%A.I.Virtanen Institute for Molecular Sciences,PO Box 1627,University of Kuopio,Kuopio FI-70211, Finland Institute of Biomedicine,Pharmacology,Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,elsinki FI-00390,Finland The WJG Press and Baishideng |
Publisher_xml | – name: Department of Internal Medicine,Kuopio University Hospital,PO Box 1777,Kuopio FI-70211,Finland – name: Foundation for Nutrition Research,PO Box 30,Helsinki FI-00390,Finland%VTT Technical Research Centre of Finland,Tietotie 2,VTT FI-02044,Finland%Institute of Biomedicine,Pharmacology, Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,Helsinki FI-00390,Finland%A.I.Virtanen Institute for Molecular Sciences,PO Box 1627,University of Kuopio,Kuopio FI-70211,Finland%A.I.Virtanen Institute for Molecular Sciences,PO Box 1627,University of Kuopio,Kuopio FI-70211, Finland – name: Foundation for Nutrition Research,PO Box 30,Helsinki FI-00390,Finland%Institute of Biomedicine,Pharmacology,Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,elsinki FI-00390, Finland – name: Institute of Biomedicine,Department of Physiology,and Biocenter of Oulu PO Box 5000,University of Oulu,Oulu FI-90014,Finland%Institute of Biomedicine, Pharmacology, Biomedicum Helsinki, PO Box 63, FI-00014 University of Helsinki,elsinki FI-00390,Finland – name: Institute of Biomedicine,Pharmacology,Biomedicum Helsinki,PO Box 63,FI-00014 University of Helsinki,elsinki FI-00390,Finland – name: The WJG Press and Baishideng |
References | ref13 ref35 ref12 ref34 ref15 ref37 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref39 ref16 ref38 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref42 ref41 ref22 ref21 ref43 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 |
References_xml | – ident: ref4 doi: 10.1053/j.gastro.2007.03.055 – ident: ref36 doi: 10.1016/j.bbalip.2007.07.007 – ident: ref20 doi: 10.1093/jn/134.11.3054 – ident: ref33 doi: 10.1016/j.plipres.2005.11.002 – ident: ref2 doi: 10.1161/ATVBAHA.107.147538 – ident: ref37 doi: 10.1016/S0163-7827(01)00020-0 – ident: ref10 doi: 10.2337/dc06-0256 – ident: ref5 doi: 10.1002/hep.21763 – ident: ref6 doi: 10.1186/1752-0509-1-12 – ident: ref42 doi: 10.1093/ajcn/22.9.1161 – ident: ref43 – ident: ref39 doi: 10.1016/S0531-5565(02)00202-4 – ident: ref7 doi: 10.2337/db07-0111 – ident: ref13 doi: 10.1136/jech.2006.053157 – ident: ref12 doi: 10.1136/jech.2006.052126 – ident: ref27 doi: 10.1093/bioinformatics/btk039 – ident: ref24 doi: 10.1038/oby.2003.52 – ident: ref22 doi: 10.1017/S0007114507764760 – ident: ref18 doi: 10.1096/fj.00-0584fje – ident: ref11 doi: 10.1001/archinte.165.9.997 – ident: ref1 doi: 10.2337/diacare.24.10.1758 – ident: ref40 doi: 10.1152/ajpendo.1999.277.2.E352 – ident: ref30 – ident: ref16 doi: 10.1038/sj.ijo.0802880 – ident: ref19 doi: 10.1016/j.jnutbio.2007.01.009 – ident: ref32 doi: 10.2217/14622416.7.7.1077 – ident: ref28 doi: 10.1186/1471-2105-6-179 – ident: ref31 doi: 10.1194/jlr.R600022-JLR200 – ident: ref41 doi: 10.1016/S0014-5793(00)01950-5 – ident: ref21 doi: 10.1080/07315724.2005.10719502 – ident: ref23 – ident: ref15 doi: 10.1093/ajcn/82.3.523 – ident: ref26 doi: 10.1371/journal.pgen.0030064 – ident: ref25 doi: 10.1016/B978-012330215-1/50008-9 – ident: ref9 doi: 10.1001/jama.287.16.2081 – ident: ref34 doi: 10.1074/jbc.M406499200 – ident: ref29 doi: 10.1371/journal.pone.0000097 – ident: ref3 doi: 10.1080/07853890510037383 – ident: ref17 doi: 10.1038/oby.2005.144 – ident: ref35 doi: 10.1073/pnas.0707060104 – ident: ref14 doi: 10.2337/diacare.28.12.2926 – ident: ref8 doi: 10.1093/ajcn/86.2.285 – ident: ref38 doi: 10.1152/physiolgenomics.00084.2006 |
SSID | ssj0023352 |
Score | 2.0469418 |
Snippet | AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated... To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated whether... AIMTo characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated... R5; AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also... AIM: To characterise the effect of energy restriction (ER) on liver lipid and primary metabolite profile by using metabolomic approach. We also investigated... |
SourceID | swepub pubmedcentral wanfang proquest crossref pubmed chongqing |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 4462 |
SubjectTerms | Animals Basic Research Blood Glucose - metabolism Body Weight - drug effects Body Weight - physiology Calcium, Dietary - pharmacology dietary calcium Dietary Proteins - pharmacology Disease Models, Animal Energy Metabolism - physiology energy restriction Fatty liver Fatty Liver - metabolism Fatty Liver - physiopathology Insulin - blood Lipid Metabolism - drug effects Lipid Metabolism - physiology Liver - metabolism Liver - pathology Male metabolomics Mice Mice, Inbred C57BL whey protein 能量限制 脂肪肝 蛋白质 钙离子 饮食调节 |
Title | Metabolomic changes in fatty liver can be modified by dietary protein and calcium during energy restriction |
URI | http://lib.cqvip.com/qk/84123X/200828/27985924.html https://www.ncbi.nlm.nih.gov/pubmed/18680224 https://search.proquest.com/docview/69395608 https://d.wanfangdata.com.cn/periodical/wjg200828006 https://pubmed.ncbi.nlm.nih.gov/PMC2731271 https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-70920 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB21PXFBIL5CKfhQjtnNOh92jlVLVSEt4kBRb5Y_t6G7TtnNCu2_79hJCqveiJRTnMjyczzz5HnPAKelM6biSqaYW-i0qK1Ka81NWmlVlo47OYteevNv1dV18fWmvDmActTCxKJ9rZqJX64mvrmNtZX3Kz0d68Sm3-fnGHJnlM2mh3CIE3Sk6APLCiKiuMWZsRSTE9aL8oLLyvTPrwWuDBNkQPEQG14FnWkRXBVuW7_4jbFiPzo9STmfVk4O_qJR8uOd9It_otPlC3g-pJXkrO_-Sziw_hXczW2HGC-D8Jj0Ct8NaTxxsut2ZBkqMgiOLFGWrFrTOMxGidoR0-Br6x2JFg7YXHqDzZa62a5Ir2okNioGSTjXY91EZcRruL788uP8Kh0OV0h1wWiXmlwZNjMW47fRBdVK8rCFZ2wZ9srqSruyzDXFdMQ5pamWGTNZ5riUVY00LcvfwJFvvX0HpNbK1JVymY0ERuHFubPBuD1nmXIJHD8OMAZnfRcspwRlNS-R_SVwOg65uO8dNgQykwCYQMCQm4gAWAKfRjgE_gFhW0N62243oqrzQPJ4Am97cP5-ZkA4AbYH22OD4K29_wSnXPTYHqZYAp97gPdeuWh-nol2vcB7K1hW0yyBkwF_MawBm9B5Gh0CcWF7_989OIZnfYkKSyn_AEfdemtPMA_q1Mc47x8AVCILKQ |
link.rule.ids | 230,315,730,783,787,888,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB2VcoALAvEVSqkP5ZjdbL7sHKtCtUC34tCi3ix_bkN3nbKbFdp_z9hJCqveiJRTnCjxiz3z5HnPAMeF1bpkUsSYW6g4r4yMK8V0XCpZFJZZMQleerOLcnqVf70urvegGLQwoWhfyXrkFsuRq29CbeXdUo2HOrHx99kphtxJSifjR_AYx2uSDyS951leRhQWORMaY3pCO1me91kZ__45x7lhhBwobGPDSq80zb2vwk3j5r8wWuzGpwdJ58Payd5hNIh-nBVu_k98OnsOz_rEkpx0H_AC9ox7Cbcz0yLKCy89Jp3Gd01qR6xo2y1Z-JoMgn1LpCHLRtcW81Eit0TXeNtqS4KJAzYXTmOzhao3S9LpGokJmkHid_ZY1UEb8Qquzj5fnk7jfnuFWOU0bWOdSU0n2mAE1ypPlRTML-JpU_jVsqpUtigylWJCYq1UqRIJ1UlimRBlhUQtyV7DvmuceQukUlJXpbSJCRRG4sGYNd66PaOJtBEc3Hcwhmd1602neEorViD_i-B46HJ-13lscOQmHjCOgCE74R6wCI4GODiOAb-wIZxpNmteVpmneSyCNx04fx_TIxwB3YHtvoF31969gj9dcNnuf7IIPnYA79zyqf5xwpvVHM8Np0mVJhEc9vjzfhZY-5dPg0cgTm3v_vsNjuDJ9HJ2zs-_XHw7gKddwQqNU_Ye9tvVxhxiVtTKD2EM_AGCWA5_ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswFCTaFCh6KVp0U7PxkB5l0dpIHYMkRpLWQQ5NkRvB1VFjU64tI_Df95GS0xi5VYBOogSJI_K9Ad8METoqrNYlkyKG3ELFeWVkXCmm41LJorDMimHw0htflec3-eVtcftkq69QtK9kPXDT2cDVd6G2cj5TyaZOLLken0DIHaZ0mMy1TV6iVzBmSbkh6j3X8lKisNBJaAwpCu2ked5rJXn4PYH5YQA8KGxlw0qvNs29t8Jd4yZ_IGJsx6hniefz-sneZTQIf5wVbvIkRo3eobd9comPu494j14Y9wHdj00LSE-9_Bh3Ot8lrh22om3XeOrrMjD0L5YGzxpdW8hJsVxjXcNtizUORg7QXDgNzaaqXs1wp23EJugGsd_dY1EHfcRHdDM6-3lyHvdbLMQqp2kb60xqOtQGorhWeaqkYH4hT5vCr5hVpbJFkakUkhJrpUqVIFQTYpkQZQVkjWSf0I5rnPmCcKWkrkppiQk0RsLBmDXevj2jRNoI7T52MIRode-Np3hKK1YAB4zQ0abL-bzz2eDATzxgHAADhsI9YBE63MDBYRz4xQ3hTLNa8rLKPNVjEfrcgfPvMT3CEaJbsD028A7b21fgxwtO2_2PFqFvHcBbt5zWv455s5jAueKUVCmJ0H6PP-9ngqV_-TT4BML09vW_3-AQvb4-HfEfF1ffd9GbrmaFxinbQzvtYmX2ITFq5UEYAn8BVh8Pkg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolomic+changes+in+fatty+liver+can+be+modified+by+dietary+protein+and+calcium+during+energy+restriction&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Taru+K+Pilvi+Tuulikki+Seppanen-Laakso+Helena+Simolin+Pier+Finckenberg+Anne+Huotari+Karl-Heinz+Herzig+Riitta+Korpela+Matej+Oresic+Eero+M+Mervaala&rft.date=2008-07-28&rft.issn=1007-9327&rft.eissn=2219-2840&rft.volume=14&rft.issue=28&rft.spage=4462&rft.epage=4472&rft_id=info:doi/10.3748%2Fwjg.14.4462&rft.externalDocID=27985924 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84123X%2F84123X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fwjg%2Fwjg.jpg |